The prospective, single-arm, single-center, exploratory clinical study of Apatinib combined with Tegafur Gimeracil Oteracil Potassium Capsule in treating patients with Advanced esophageal squamous carcinoma

Trial Profile

The prospective, single-arm, single-center, exploratory clinical study of Apatinib combined with Tegafur Gimeracil Oteracil Potassium Capsule in treating patients with Advanced esophageal squamous carcinoma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2017

At a glance

  • Drugs Apatinib (Primary) ; Gimeracil (Primary) ; Oteracil (Primary) ; Potassium (Primary) ; Tegafur (Primary)
  • Indications Oesophageal cancer; Squamous cell cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top